Related Experiment Video
Updated: Dec 6, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Computer-generated "synthetic contingency" plans at times of logistics and supply problems: scenarios for
Sara Szymkuć1, Ewa P Gajewska1, Karol Molga1
1Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
Abstract:
A computer program for retrosynthetic planning helps develop multiple "synthetic contingency" plans for hydroxychloroquine and also routes leading to remdesivir, both promising but yet unproven medications against COVID-19. These plans are designed to navigate, as much as possible, around known and patented routes and to commence from inexpensive and diverse starting materials, so as to ensure supply in case of anticipated market shortages of commonly used substrates. Looking beyond the current COVID-19 pandemic, development of similar contingency syntheses is advocated for other already-approved medications, in case such medications become urgently needed in mass quantities to face other public-health emergencies.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Dosage Regimens: Designs and Approaches
Dosage Regimen: Individualization
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Products: Biologics, Biosimilars and Interchangeables